Breast Unit, Department of Surgery, Guglielmo da Saliceto Hospital, Piacenza, Italy -
Breast Unit, Department of Surgery, Guglielmo da Saliceto Hospital, Piacenza, Italy.
Minerva Surg. 2022 Oct;77(5):473-480. doi: 10.23736/S2724-5691.21.08941-3. Epub 2021 Oct 25.
Breast cancer is the second leading cause of death in women. The most recent and successful advancement in implant-assisted breast reconstruction after mastectomy is the prepectoral approach using an acellular dermal matrix (ADM). Patients with ptotic breasts and macromastia were initially excluded from this type of immediate reconstruction remaining a difficult group to treat. The aim of this paper is to present our experience in performing skin-reducing mastectomy with pre-pectoral implant and complete ADM coverage as a single-stage procedure in patients with large ptotic breasts, evaluating the benefits and complications resulting from the use of this technique.
A retrospective analysis of skin-reducing mastectomies and pre-pectoral breast reconstructions using Braxon porcine-derived ADM performed between January 2019 and February 2021 at our Breast Unit.
We treated 20 patients and performed a total of 24 skin-reducing mastectomies with pre-pectoral reconstruction. We observed two cases of partial NAC necrosis (8.3%) and one case of total NAC necrosis (4.2%). The incidence of skin flap necrosis was 8.3% (N.=2) healed by secondary intention. No case of prosthesis removal, infection or seroma was reported. Patients scored very good level of satisfaction with breast based on the results of the BREAST- Q questionnaire.
Skin-reducing mastectomy and pre-pectoral breast reconstruction can be offered to patients with large and ptotic breasts with good aesthetic and functional results. New prospective observational studies would be desirable to provide an opportunity to evaluate the long-term capabilities and complications of this technique.
乳腺癌是女性死亡的第二大主要原因。在乳房切除术后,使用脱细胞真皮基质 (ADM) 的假体辅助乳房重建是最新和最成功的进展。最初,有乳房下垂和巨乳症的患者被排除在这种即时重建之外,仍然是一个难以治疗的群体。本文旨在介绍我们在使用前置假体和完整 ADM 覆盖进行皮肤减少乳房切除术方面的经验,作为一种在大乳房下垂患者中进行的单阶段手术,评估使用该技术的益处和并发症。
对 2019 年 1 月至 2021 年 2 月在我们的乳房科进行的使用 Braxon 猪源性 ADM 的皮肤减少乳房切除术和前置乳房重建进行回顾性分析。
我们治疗了 20 名患者,共进行了 24 例前置假体乳房重建的皮肤减少乳房切除术。我们观察到 2 例部分 NAC 坏死(8.3%)和 1 例 NAC 全部坏死(4.2%)。皮瓣坏死的发生率为 8.3%(N.=2),通过二期愈合。未报告假体取出、感染或血清肿的病例。根据 BREAST-Q 问卷的结果,患者对乳房的满意度评分非常好。
对于大乳房和乳房下垂的患者,可以提供皮肤减少乳房切除术和前置假体乳房重建,以获得良好的美学和功能效果。新的前瞻性观察性研究将是理想的,以提供机会评估该技术的长期能力和并发症。